6-(4-氯苯氧基)己腈 | 100116-45-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 6-(4-氯苯氧基)己腈
• 英文名称: 6-(4-chlorophenoxy)hexanenitrile
• 英文别名: 6-(4-Chlor-phenoxy)-hexannitril；6-(4-Chloro-phenoxy)-hexanenitrile
• CAS: 100116-45-8
• 化学式: C₁₂H₁₄ClNO
• 分子量: 223.702
• InChiKey: KKLLBNYOGNBALG-UHFFFAOYSA-N

物化性质

• 熔点：
  47-48 °C
• 沸点：
  373.7±22.0 °C(Predicted)
• 密度：
  1.111±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  15
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  33
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  6-(4-氯苯氧基)己腈 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 反应 0.5h， 以49%的产率得到6-(4-氯苯氧基)己烷-1-胺
  参考文献：
  名称：

  Synthesis and biological evaluation of new non-imidazole H3-receptor antagonists of the 2-aminobenzimidazole series

  摘要：

  A novel series of non-imidazole H-3-receptor antagonists was developed, by chemical modification of a potent lead H-3-antagonist composed by an imidazole ring connected through an alkyl spacer to a 2-aminobenzimidazole moiety (e.g., 2-[[3-[4(5)-imidazolyl]propyl]amino]benzimidazole), previously reported by our research group. We investigated whether the removal of the imidazole ring could allow retaining high affinity for the H-3-receptor, thanks to the interactions undertaken by the 2-aminobenzimidazole moiety at the binding site. The imidazole ring of the lead was replaced by a basic piperidine or by a lipophilic p-chlorophenoxy substituent, modulating the spacer length from three to eight methylene groups; moreover, the substituents were moved to the 5(6) position of the benzimidazole nucleus. Within both the 2-alkylaminobenzimidazole series and the 5(6)-alkoxy-2-amino-benzimidazole one, the greatest H-3-receptor affinity was obtained for the piperidine-substituted compounds, while the presence of the p-chlorophenoxy group resulted in a drop in affinity. The optimal chain length was different in the two series. Even if the new compounds did not reach the high receptor affinity shown by the imidazole-containing lead compound, it was possible to get good H-3-antagonist potencies with 2-aminobenzimidazoles having a tertiary amino group at appropriate distance. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2005.09.063
• 作为产物：
  描述：

  1,5-二溴戊烷 在 sodium cyanide 、 氢氧化钾 、 乙醇 作用下， 生成 6-(4-氯苯氧基)己腈
  参考文献：
  名称：

  植物生长物质：ω-芳基-和ω-芳氧基-烷基羧酸

  摘要：

  结合植物生长活性的研究，合成了许多 R[CH2]CO2H 型羧酸。它们包括 ω-取代的烷基羧酸的五个同源系列的前六或七个成员，即邻甲氧基苯氧基-、对氯苯氧基-、2:4-二氯苯氧基-、2:4:5-三氯苯氧基-和 1-萘基-烷基羧酸；和五个1-萘基-烷基羧酸，其中烷基链被支化或以其他方式改性。苯氧酸是通过经典方法制备的，但对于许多 1-萘酸，采用了涉及使用有机镉化合物的方法。

  DOI：

  10.1002/jsfa.2740070504

文献信息

• Derivatives of squaric acid with anti-proliferative activity
  申请人：GPC Biotech AG

  公开号：EP1674457B1

  公开（公告）日：2009-06-03
• US8450348B2
  申请人：——

  公开号：US8450348B2

  公开（公告）日：2013-05-28
• Plant-growth substances: ω-aryl- and ω-aryloxy-alkylcarboxylic acids
  作者：K. Gaimster

  DOI：10.1002/jsfa.2740070504

  日期：1956.5

  carboxylic acids of the type R[CH2] CO2H have been synthesized in connexion with studies of plant-growth activity. They include the first six or seven members of five homologous series of ω-substituted alkylcarboxylic acids, namely o-methoxyphenoxy-, p-chlorophenoxy-, 2:4-dichlorophenoxy-, 2:4:5-trichlorophenoxy- and 1-naphthyl-alkylcarboxylic acids; and five 1-naphthyl-alkylcarboxylic acids in which

  结合植物生长活性的研究，合成了许多 R[CH2]CO2H 型羧酸。它们包括 ω-取代的烷基羧酸的五个同源系列的前六或七个成员，即邻甲氧基苯氧基-、对氯苯氧基-、2:4-二氯苯氧基-、2:4:5-三氯苯氧基-和 1-萘基-烷基羧酸；和五个1-萘基-烷基羧酸，其中烷基链被支化或以其他方式改性。苯氧酸是通过经典方法制备的，但对于许多 1-萘酸，采用了涉及使用有机镉化合物的方法。
• Synthesis and biological evaluation of new non-imidazole H3-receptor antagonists of the 2-aminobenzimidazole series
  作者：Mirko Rivara、Valentina Zuliani、Giuseppe Cocconcelli、Giovanni Morini、Mara Comini、Silvia Rivara、Marco Mor、Fabrizio Bordi、Elisabetta Barocelli、Vigilio Ballabeni、Simona Bertoni、Pier Vincenzo Plazzi

  DOI：10.1016/j.bmc.2005.09.063

  日期：2006.3

  A novel series of non-imidazole H-3-receptor antagonists was developed, by chemical modification of a potent lead H-3-antagonist composed by an imidazole ring connected through an alkyl spacer to a 2-aminobenzimidazole moiety (e.g., 2-[[3-[4(5)-imidazolyl]propyl]amino]benzimidazole), previously reported by our research group. We investigated whether the removal of the imidazole ring could allow retaining high affinity for the H-3-receptor, thanks to the interactions undertaken by the 2-aminobenzimidazole moiety at the binding site. The imidazole ring of the lead was replaced by a basic piperidine or by a lipophilic p-chlorophenoxy substituent, modulating the spacer length from three to eight methylene groups; moreover, the substituents were moved to the 5(6) position of the benzimidazole nucleus. Within both the 2-alkylaminobenzimidazole series and the 5(6)-alkoxy-2-amino-benzimidazole one, the greatest H-3-receptor affinity was obtained for the piperidine-substituted compounds, while the presence of the p-chlorophenoxy group resulted in a drop in affinity. The optimal chain length was different in the two series. Even if the new compounds did not reach the high receptor affinity shown by the imidazole-containing lead compound, it was possible to get good H-3-antagonist potencies with 2-aminobenzimidazoles having a tertiary amino group at appropriate distance. (c) 2005 Elsevier Ltd. All rights reserved.